Showing results (511-520 of 560) with videos related to

Sort By:
Pageof 56
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report]H Tanemura, R Kawata, M Suzuki, et al.
Immunity|March 1, 1995
Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normalR Nishinakamura, N Nakayama, Y Hirabayashi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|December 26, 2001
Mammalian homologue of E. coli Ras-like GTPase (ERA) is a possible apoptosis regulator with RNA binding activityT Akiyama, J Gohda, S Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]Y Sugiyama, M Kato, H Takao, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer]K Miya, S Saji, T Furuta, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1990
[A case of metastatic malignant melanoma of the stomach treated by a surgical operation]T Suhara, S Azuma, M Hayakawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|December 1, 1990
[Relationship between the prognosis and nuclear DNA histograms in gastric cancer patients with a synchronous liver metastases who were given a combined gastrectomy and hepatectomy]H Tanemura, S Saji, T Chikaishi, et al.
Annals of Hematology|January 25, 2002
Acute rhabdomyolysis following administration of high-dose cyclophosphamide: case reportE Shima, M Hino, T Yamane, et al.
Japanese Heart Journal|September 1, 1996
Selective radiofrequency catheter ablation of the slow pathway for common and uncommon atrioventricular nodal reentrant tachycardiaY Iesaka, A Takahashi, M Goya, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 13, 2001
[CD13- and CD33-negative acute myelocytic leukemia (FAB classification; M2) with morphological changes and CD13 expression on recurrence]Y Aoyama, T Yamane, H Kanashima, et al.
Pageof 56